Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antigen-Loaded DC Vaccination in Hormone-Refractory Prostate Cancer
NCT01897207Phase 2Completed
- Start
- Nov 2002
- Primary completion
- Aug 2009
- Modality
- Prophylactic Vaccines, Whole Cell Cancer Vaccines, Dendritic Cell Vaccines
01
Overview
A Phase 2 trial of autologous dendritic cell vaccine in prostate cancer (PCa). Started Nov 2002; status: completed.
02
Drugs
autologous dendritic cell vaccine
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT01897207.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01897207.